Literature DB >> 6540402

The fate of severed corticospinal axons.

P S Fishman, J P Kelley.   

Abstract

The potential for regeneration of severed corticospinal axons was examined by labeling these axons with horseradish peroxidase following thoracic spinal cord transections in mice. Shortly after severance, the proximal ends of corticospinal axons formed terminal bulbs that persisted for weeks and were associated with axonal retraction. There were few signs of corticospinal axonal sprouting or elongation. By 2 months after injury, corticospinal axons near the transection site showed an increased number of probable labeled terminals in the adjacent gray matter. These new terminals may contribute to the persistence of many corticospinal axons near the injury site long after a spinal cord transection.

Entities:  

Mesh:

Year:  1984        PMID: 6540402     DOI: 10.1212/wnl.34.9.1161

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Changes in the distribution of synaptic potentials from bulbospinal neurones following axotomy in cat thoracic spinal cord.

Authors:  T W Ford; C W Vaughan; P A Kirkwood
Journal:  J Physiol       Date:  2000-04-01       Impact factor: 5.182

2.  Expression and activation of ephexin is altered after spinal cord injury.

Authors:  Odrick R Rosas; Johnny D Figueroa; Aranza I Torrado; Mónica Rivera; José M Santiago; Franchesca Konig-Toro; Jorge D Miranda
Journal:  Dev Neurobiol       Date:  2011-07       Impact factor: 3.964

Review 3.  Imaging techniques in spinal cord injury.

Authors:  Benjamin M Ellingson; Noriko Salamon; Langston T Holly
Journal:  World Neurosurg       Date:  2012-12-12       Impact factor: 2.104

4.  Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions.

Authors:  Kevin P Horn; Sarah A Busch; Alicia L Hawthorne; Nico van Rooijen; Jerry Silver
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.